Kristen Alexander is VP, Finance and Accounting of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,800 shares of LXRX, which is worth approximately $39,674. The most recent transaction as insider was on Feb 28, 2024, when has been sold 11,793 shares (Common Stock) at a price of $2.62 per share, resulting in proceeds of $30,897. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.8K
0% 3M change
57.5% 12M change
Total Value Held $39,674

Kristen Alexander Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2024
SELL
Payment of exercise price or tax liability
$30,897 $2.62 p/Share
11,793 Reduced 19.79%
47,800 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
29,243 Added 32.92%
59,593 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$11,566 $2.17 p/Share
5,330 Reduced 14.94%
30,350 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
18,717 Added 34.41%
35,680 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$9,510 $2.85 p/Share
3,337 Reduced 16.44%
16,963 Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
11,300 Added 35.76%
20,300 Common Stock
KA

Kristen Alexander

VP, Finance and Accounting
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX